TABLE 2.
PIFR group (n = 160) | Control group (n = 223) | Incidence rate ratio (PIFR group to control group) | p value | |
---|---|---|---|---|
Total AE | 0.88 (0.71–1.06) | 1.14 (0.94–1.34) | 0.84 (0.62–1.13) | 0.245 |
Mild AE | 0.11 (0.06–0.16) | 0.17 (0.11–0.23) | 0.68 (0.37–1.23) | 0.203 |
Moderate AE | 0.55 (0.42–0.68) | 0.55 (0.28–0.57) | 1.11 (0.79–1.57) | 0.546 |
Severe AE | 0.18 (0.09–0.27) | 0.43 (0.28–0.57) | 0.52 (0.32–0.87) | 0.012 |
Moderate-severe AE | 0.77 (0.60–0.94) | 0.98 (0.79–1.16) | 0.88 (0.64–1.20) | 0.401 |
Data presented as mean (95% confidence intervals). AE: acute exacerbation. Incidence rate was calculated as events/patient/year. PIFR group: patients who received PIFR-guided inhalation therapy.